Genomic medicine has the potential to revolutionize the treatment of heart valve disease by enabling personalized approaches tailored to individual genetic profiles. This article reviews the current state of genomic medicine in heart valve disease, including genetic underpinnings, advancements in personalized treatment strategies, and future directions. We explore how genomic insights are being utilized to improve diagnosis, predict disease progression, and optimize therapeutic interventions.